Bain Capital Life Sciences

New York
Firm Location:New York • Massachusetts • New York, New York • Boston, Massachusetts
Bain Capital Life Sciences Team
Photo of Jonah Cashdan, Vice President at Bain Capital Life Sciences
Jonah Cashdan
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in New York (NY)
Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in New York City (Other Lists), Investors in BioTech (Series A), Investors in BioTech (Series B)
Photo of Michael Cooney, Associate at Bain Capital Life Sciences
Michael Cooney
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA)
Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in BioTech (Series B), Investors in Boston / New England (Other Lists)
Photo of Adam Koppel, Managing Director at Bain Capital Life Sciences
Adam Koppel
Bain Capital Life Sciences·Managing Director
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston / New England, Investors in Boston (MA), Investors in Massachusetts
Photo of Benjamin Lund, Principal at Bain Capital Life Sciences
Benjamin Lund
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA)
Photo of Harris Weber, Vice President at Bain Capital Life Sciences
Harris Weber
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in New York
Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in BioTech (Series A)
Photo of Julie Yang, Associate at Bain Capital Life Sciences
Julie Yang
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA)
Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in BioTech (Series B), Investors in Boston / New England (Other Lists)